PANEL Valuations and Estate Planning: Impact of Covid

What are the valuation implications of the current economic environment brought about by the economic implications and stock market’s reaction to the COVID-19 crisis. The program will discuss the practical ramifications to valuations and the implications to estate planning transactions. A number of factors may have aligned for what is potentially a unique opportunity to maximize the efficient use of exclusion amounts and transfer significant wealth at a relatively lower cost. The relevance of the valuation date in the valuation of a private business in the midst of this crisis will be discussed in detail. Even though markets may have recovered from lows opportunity remains for sophisticated wealth transfer planning. The panel of valuation experts and estate planners will also discuss nuances to valuation methodologies that the appraiser and client must consider in light of the Covid crisis. Company-specific items such as the usage of PPP loans, and the implications of the CARES Act generally, will be reviewed. Why and how forward-looking projections are more important to the valuation process with expected fluctuations in cash flows over the next few months and perhaps years. The panel will discuss the fluctuation of valuation discounts for private businesses. It is anticipated that many clients will transfer substantial wealth before the November 2020 election for fear that the election might bring reduction in gift and GST exemptions, restriction or eliminate of discounts and GRATs. The program will provide technical but practical valuation insights that practitioners will need to understand in guiding clients planning in the last half of 2020.

There are no professional advancement credits (CPE, CLE, etc.) offered for viewing this webinar.

Speakers: Todd G. Povlich, CFA, ASA, Dan Kerrigan, CFA, ASA, Scott Nammacher, CFA, ASA, Kevin Kane, CFA, ASA, Jonathan Blattmachr, Esq. and Martin Shenkman, Esq.

Sponsor: Interactive Legal and Peak Trust

Featured Charity: Weizmann Institute of Science See www.weizmann-usa.org